Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation

Cited 51 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorM H Lee-
dc.contributor.authorYeesook Cho-
dc.contributor.authorY M Han-
dc.date.accessioned2017-04-19T09:07:44Z-
dc.date.available2017-04-19T09:07:44Z-
dc.date.issued2007-
dc.identifier.issn1066-5099-
dc.identifier.uri10.1634/stemcells.2006-0753ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/8003-
dc.description.abstractStatins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, were originally developed to lower cholesterol. Their pleiotropic (or cholesterol-independent) effects at the cellular and molecular levels are highly related to numerous cellular functions, such as proliferation and differentiation. However, they are hardly studied in embryonic stem cells. In this study, we evaluated the effects of statins on mouse ESCs (J1, D3, and RW.4) to enhance our understanding of the molecular basis of ESC self-renewal. Treatment of ESCs with simvastatin, mevastatin, atorvastatin, or pravastatin induced morphological change and decreased cell proliferation. We observed that the use of simvastatin was most effective in all three ESCs. Loss of ESC self-renewal by simvastatin was determined by marked downregulation of ESC markers alkaline phosphatase, Oct4, Nanog, Rex-1, and SSEA-1. Simvastatin effects were selectively reversed by either mevalonate or its metabolite geranylgeranyl pyrophosphate (GGPP) but not by cholesterol or farnesyl pyrophosphate. These results suggest that simvastatin effects were mainly derived from depletion of intracellular pools of GGPP, the substrate required for the geranylgeranylation. Using this approach, we found that GGPP, a derivative of the mevalonate pathway, is critical for ESC self-renewal. Furthermore, we identified that simvastatin selectively blocked cytosol-to-membrane translocalization of RhoA small guanosine triphosphate-binding protein, known to be the major target for geranylgeranylation, and lowered the levels of Rho-kinase (ROCK)2 protein in ESCs. In addition, simvastatin downregulated the ROCK activity, and this effect was reversed by addition of GGPP. Our data suggest that simvastatin, independently of its cholesterol-lowering properties, impairs the ESC self-renewal by modulating RhoA/ROCK-dependent cell-signaling.-
dc.publisherWiley-
dc.titleSimvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation-
dc.title.alternativeSimvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation-
dc.typeArticle-
dc.citation.titleStem Cells-
dc.citation.number7-
dc.citation.endPage1663-
dc.citation.startPage1654-
dc.citation.volume25-
dc.contributor.affiliatedAuthorYeesook Cho-
dc.contributor.alternativeName이미희-
dc.contributor.alternativeName조이숙-
dc.contributor.alternativeName한용만-
dc.identifier.bibliographicCitationStem Cells, vol. 25, no. 7, pp. 1654-1663-
dc.identifier.doi10.1634/stemcells.2006-0753-
dc.subject.keywordgeranylgeranyl pyrophosphate-
dc.subject.keywordMouse embryonic stem cells-
dc.subject.keywordRhoA-
dc.subject.keywordself-renewal-
dc.subject.keywordsimvastatin-
dc.subject.localgeranylgeranyl pyrophosphate-
dc.subject.localMouse embryonic stem cells (mESCs)-
dc.subject.localMouse embryonic stem cells-
dc.subject.localRHOA-
dc.subject.localRhoA-
dc.subject.localSelf-renewal-
dc.subject.localself-renewal-
dc.subject.localsimvastatin-
dc.description.journalClassY-
Appears in Collections:
Division of Biomedical Research > Immunotherapy Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.